CarboCalyx GmbH is a glycopharmaceutical startup company dedicated for the establishment of novel immunomodulatory biologics using cellular modifications, glycoengineering and targeted immunotherapy. Our technologies are suitable for clinical testing in various disease conditions. We aim to develop personalized vaccination methodologies for patients fighting against cancer and to generate a repertoire of innovative opportunities to control infectious diseases.
Company Details
- Founded
- -
- Address
- Byk-Gulden Straße 2, The Plant,bdg. 7,fl. 3,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.carbocalyx.com/
- HQ
- Constance, Baden-Württemberg
Carbocalyx Gmbh Questions
Carbocalyx Gmbh's website is https://www.carbocalyx.com/
Carbocalyx Gmbh's LinkedIn profile is https://www.linkedin.com/company/carbocalyx
Carbocalyx Gmbh's industry is
Pharmaceutical Manufacturing
Carbocalyx Gmbh's top competitors are
Fairjourney Biologics,
Microharvest,
Trenzyme Gmbh,
A4f-Algae For Future,
Uwork Global,
Carbocode,
Eugenex Biotechnologies Gmbh,
Biotrend Sa,
Biocant Park.
Carbocalyx Gmbh's categories are Pharmaceutical Manufacturing
Carbocalyx Gmbh's founding year is 2019
